Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.

By B. Yıldız, G. Bozdag, Z. Yapıcı, I. Esinler, H. Yarali. Human Reproduction, 2012

658 citations recorded by the source corpus.

Subfields: Molecular Biology, Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/4f7ce6eaf52caa50fc5b2bc948123e90ae1576d8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. Kristen A Pate
2. Susan M. Sirmans

In Reproductive Medicine

1. Kristen A Pate
2. Susan M. Sirmans

Citations in the corpus

• The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. (2016, background): “…/hum rep/article-abstract/31/12/2841/2730240 by guest on 16 M arch 2020 presented higher prevalence with Rotterdam (March et al., 2010; Mehrabian et al., 2011; Eilertsen et al., 2012; Yildiz et al., 2012; Lauritsen et al., 2014; Rashidi et al., 2014; Tehrani et al., 2014; Zhuang et al., 2014).”
• Epidemiology, diagnosis, and management of polycystic ovary syndrome (2013, methodology): “32 These studies consistently report that the prevalence estimates using the Rotterdam criteria are two to three times greater than those obtained using the NIH/NICHD criteria.”